Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Vermont
M.D. Anderson Cancer Center
University Hospital, Toulouse
French Innovative Leukemia Organisation
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital